Additionally, CAR-T cells engineered with decoy receptors that bind and neutralize immunosuppressive factors, such as transforming growth factor-β (TGF-β), have demonstrated increased proliferation, enhanced cytokine secretion, resistance to exhaustion, prolonged persistence, and potent tumor eradication in aggressive human prostate cancer models [124]. This evidence concerns the gene TGFB1 and neoplasm.